Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Hepatocarcinoma|Lung Cancer|Melanoma|Renal Cancer|Head and Neck Cancer|Pancreas Cancer|Ovarian Cancer|Colo-rectal Cancer|Cervical Cancer|Breast Cancer
Interventions: DRUG: Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy
Sponsor: Second Affiliated Hospital of Guangzhou Medical University